Essayer OR - Gratuit
Amagi IPO to test mkts with valuation reset
Mint Chennai
|January 13, 2026
Nearly 90% of Amagi Media Labs' revenue comes from the US and Europe and no Indian peer operates at a comparable scale.
Amagi Media Labs will open its ₹1,789 crore initial public offering (IPO) on 13 January, making it one of the first companies in 2026 to test public market appetite for a difficult-to-price global brand. The IPO comprises a ₹816 crore fresh issue and a ₹973 crore offer for sale.
Built in India and deployed worldwide, Amagi sells a cloud-based operating system that media companies use to run, distribute and monetize TV channels without owning broadcast infrastructure. Nearly 90% of its revenue comes from the US and Europe, the world’s largest advertising markets, and no Indian peer operates at a comparable scale.
Even globally, few companies span the full cloud value chain of media distribution the way Amagi does, according to its offer documents. While that positioning gives the company along growth runway, the lack of clear listed comparables leaves investors without an obvious benchmark.
Investors are being asked to judge Amagi largely on its earningstrajectory and how quickly this niche technology becomes mainstream, said Yatin Singh, chief executive officer (CEO) of investment banking at Emkay Global Financial Services. This uncertainty that is shaping the pricing of the IPO and expectations from the stock, said Singh.
Cette histoire est tirée de l'édition January 13, 2026 de Mint Chennai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
